Gara Jalqabaatti › Adenokaarsinomaa Esophagus › Virginia › Arlington
Qorannoo klinikaalii Adenokaarsinomaa Esophagus Arlington, VA keessatti
Qorannoo 11 Adenokaarsinomaa Esophagus f Arlington fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Namoota walitti qabaa jiraSadarkaa 3
- Inova Fairfax Hospital, Falls Church · Miili 4 fagaatti
- Inova Schar Cancer Institute, Fairfax · Miili 11 fagaatti
- Inova Fair Oaks Hospital, Fairfax · Miili 11 fagaatti
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Namoota walitti qabaa jiraSadarkaa 1/2
- Inova Schar Cancer Institute, Fairfax · Miili 11 fagaatti
- Virginia Cancer Specialists, PC, Fairfax · Miili 11 fagaatti
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Namoota walitti qabaa jiraSadarkaa 2/3
- Virginia Cancer Specialists, PC, Arlington
- Virginia Cancer Specialists, PC, Fairfax · Miili 11 fagaatti
- Virginia Cancer Specialists, PC, Reston · Miili 14 fagaatti
- fi 1 dabalataa
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Oncology Virginia, Fairfax · Miili 11 fagaatti
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Fairfax · Miili 11 fagaatti
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Normunity Investigational Site, Fairfax · Miili 11 fagaatti
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Namoota walitti qabaa jiraSadarkaa 1/2
- Virginia Cancer Specialists, Fairfax · Miili 11 fagaatti
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Virginia Cancer Specialists, Fairfax · Miili 11 fagaatti
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Virginia Cancer Specialists, Fairfax · Miili 11 fagaatti
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Research Site, Fairfax · Miili 11 fagaatti
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Virginia, Fairfax · Miili 11 fagaatti
Qorannoo Adenokaarsinomaa Esophagus magaalota biroo keessatti
- New York City, NYQorannoo 18
- Boston, MAQorannoo 13
- Houston, TXQorannoo 12
- Nashville, TNQorannoo 11
- Durham, NCQorannoo 10
- Rochester, MNQorannoo 9
- Baldwin Park, CAQorannoo 9
- St. Louis, MOQorannoo 9
- Jacksonville, FLQorannoo 9
- Queens, NYQorannoo 9
- Los Angeles, CAQorannoo 9
- Philadelphia, PAQorannoo 8
Qorannoo biroo Arlington keessatti
- Kansara Qara'a Non-Small CellQorannoo 104
- Kansara MetastatikiiQorannoo 53
- Kansarii ColorectalQorannoo 52
- Saree (Gosoota Hunda)Qorannoo 48
- Saree OljooQorannoo 47
- Kansarii OvariiQorannoo 46
- Dhibee QaraQorannoo 41
- Kansa EndometiriyaaliiQorannoo 39
- Kansarii PancreasQorannoo 33
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 26
- Kansarii Hafuu Seli XiqqaaQorannoo 23
- Kanisa HarkaaQorannoo 20
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.